Immuron (IMRN) Consolidated Net Income (2016 - 2024)
Immuron's (IMRN) quarterly Consolidated Net Income came in at $37.9 billion in Q4 2024, up 1829989.51% year-on-year from N/an in Q1 2024, and up 1829989.51% quarter-over-quarter from -$2.1 million in Q4 2023.
Immuron (IMRN) Consolidated Net Income (2016 - 2024) Analysis & Trends
Immuron's Consolidated Net Income history runs 9 years deep, the most recent figure standing at $37.9 billion for Q4 2024.
- On a quarterly basis, Consolidated Net Income rose 1829989.51% year-over-year to $37.9 billion in Q4 2024; TTM through Sep 2025 was $37.9 billion, a 1829989.51% increase from a year earlier, with the FY2025 full-year figure at -$3.4 million, down 227575.8% from the prior year.
- Consolidated Net Income advanced to $37.9 billion in Q4 2024 per IMRN's latest filing, from -$2.1 million in the prior quarter.
- Across five years, Consolidated Net Income topped out at $37.9 billion in Q4 2024 and bottomed at -$2.1 million in Q4 2023.
- The 5-year median for Consolidated Net Income is -$204929.1 (2022), against an average of $6.3 billion.
- Across the five-year window, Consolidated Net Income tumbled 2558.11% in 2022 and jumped 1829989.51% in 2024, its largest moves.
- Year by year, Consolidated Net Income stood at -$57387.7 in 2020, then soared by 76.89% to -$13260.2 in 2021, then tumbled by 2558.11% to -$352470.5 in 2022, then slumped by 488.19% to -$2.1 million in 2023, then soared by 1829989.51% to $37.9 billion in 2024.
- Per Business Quant, the three latest IMRN Consolidated Net Income figures stand at $37.9 billion (Q4 2024), -$2.1 million (Q4 2023), and -$1.2 million (Q2 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -37.09 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Immuron | 255.19 Mn | 243.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 37.94 Bn |
| Dec 31, 2023 | -2.07 Mn |
| Jun 30, 2023 | -1.24 Mn |
| Dec 31, 2022 | -352,470.52 |
| Dec 31, 2021 | -13,260.17 |
| Dec 31, 2020 | -57,387.72 |
| Dec 31, 2019 | -15,212.27 |
| Dec 31, 2018 | -1.58 Mn |
| Dec 31, 2017 | -1.45 Mn |
| Dec 31, 2016 | -2.60 Mn |
| Jun 30, 2016 | -3.28 Mn |